The deal allows Aurora stock to invest and see Growery create a new facility, fund early operations, and operational help.
The Netherlands is expected to be the largest federally regulated recreational market outside of Canada, and is a proof point that our medical market success in Europe is portable to recreational markets,” said Miguel Martin, chief executive officer of Aurora Cannabis.
But perhaps companies like Canopy Growth, Tilray, and HEXO won’t need to expand if they can recreate the experiment where they have a hold.
While this kind of experiment won’t be the United States quite yet, it could create an opportunity in Canada.
Canopy Growth, after hitting two-year lows, climbed 8%, just like Aurora stock.
This could be positive, but I might want to take a wait-and-see approach.
Finally, the experiment is in 80 coffee shops that have signed on for at least four years.
So, if you’re a long-term Motley Fool investor, it may be a good time to see some slow and steady growth for the next decade and beyond from Aurora stock and other cannabis stocks to boot.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor.